(June 11, 2024, 2:11 PM EDT) -- TRENTON, N.J. — Five patents listed by Teva Pharmaceuticals Inc. with the U.S. Food and Drug Administration in connection with a new drug application (NDA) for ProAir HFA (albuterol sulfate) Inhalation Aerosol do not cover albuterol sulfate, a federal judge in New Jersey found June 10, granting judgment on delisting counterclaims by Amneal Pharmaceuticals Inc. and others, which were backed by the U.S. Federal Trade Commission as amicus curiae....